Purpose Pharmacokinetic considerations in patients who have undergone Roux-en-Y gastric bypass (RYGB) are explored. Summary The prevalence of obesity, especially morbid obesity, has dramatically ...

Pharmacokinetic Considerations in Roux-en-Y Gastric Bypass Patients April Smith; Brian Henriksen; Andrew Cohen Disclosures Am J Health Syst Pharm. 2011;68 (23):2241-2247.

Bariatric surgery is a medical procedure that alters the digestive system to help individuals with obesity lose weight by ...

Amylyx reports strong Phase 2b trial data for avexitide, showing 64% fewer hypoglycemic events in patients with post-bariatric hypoglycemia.

We looked for studies that compared the uncut Roux-en-Y reconstruction with other types of reconstruction (Billroth I, Billroth II, and regular Roux-en-Y) after a distal gastrectomy for stomach cancer ...